Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics ...

(Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

Infertility is a major global challenge associated with physiological and psychological impact. Genetic mutations that affect ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

New facility to support advancements in molecular diagnostics, rare disease research, and industrial microbiology ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

Although compact Un1Cas12f1 has improved, low gene editing activity was observed ... Here, the authors develop a high-fidelity RNA-targeting CRISPR system to suppress the repeat RNA expressed ...